Illumina, Inc. - Common Stock (NQ:ILMN)

273.04 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

39 40 Next >

Molina Healthcare, Coty, Illumina, Amazon And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

February 06, 2026

Via Benzinga

ILMN Q4 Deep Dive: Clinical Consumables Growth, Multiomics Expansion, and Margin Momentum

February 06, 2026

Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 5% year on year to $1.16 billion. The company’s full-year revenue guidance of $4.55 billion...

Via StockStory

Illumina Inc (NASDAQ:ILMN) Stock Falls Despite Q4 Earnings Beat on Cautious 2026 Outlook ↗

February 05, 2026

Via Chartmill

Topics Earnings

Illumina (ILMN) Q4 2025 Earnings Call Transcript ↗

February 05, 2026

Illumina (ILMN) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Illumina (NASDAQ:ILMN) Reports Bullish Q4 CY2025

February 05, 2026

Via StockStory

SBIR Eligibility Requirements: Small Business Qualification Guide Released

February 05, 2026

Via Press Release Distribution Service

Topics Intellectual Property

Cold Chain, High Stakes: A Deep Dive into Azenta’s (AZTA) Life Sciences Transformation

February 05, 2026

Date: February 5, 2026 Introduction In the high-stakes world of life sciences, the "cold chain" is the invisible backbone of modern medicine. From the development of mRNA vaccines to the emerging...

Via Finterra

Topics Artificial Intelligence Earnings Economy

Illumina (ILMN) Reports Q4: Everything You Need To Know Ahead Of Earnings

February 03, 2026

Genomics company Illumina (NASDAQ:ILMN) will be reporting results this Thursday after market close. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence

The Analyst Verdict: Illumina In The Eyes Of 15 Experts ↗

January 26, 2026

Via Benzinga

The Silicon Ceiling Shatters: S&P 500’s Historic Ascent Past 5,300 and the AI Anchor

January 23, 2026

In a definitive display of market resilience, the S&P 500 (CME:GSPC) achieved a landmark milestone in May 2024, crossing the 5,300 threshold for the first time in history. This surge, culminating in a...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years ↗

January 22, 2026

Via Benzinga

Life Sciences Tools & Services Stocks Q3 Teardown: Illumina (NASDAQ:ILMN) Vs The Rest

January 21, 2026

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and its peers.

Via StockStory

Topics Artificial Intelligence

Illumina Gets Medicare Boost for Cancer Test, Shares Climb ↗

January 20, 2026

Illumina shares rose after Medicare approved reimbursement for its FDA-approved cancer test, a move expected to drive growth.

Via Benzinga

3 Cash-Producing Stocks with Open Questions

January 18, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Via StockStory

Topics Artificial Intelligence

3 Inflated Stocks We Approach with Caution

January 15, 2026

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial...

Via StockStory

GRAIL Surges as Canaccord Genuity Sets Ambitious $105 Price Target Following Robust 2025 Growth

January 13, 2026

In a resounding vote of confidence for the future of multi-cancer early detection (MCED), Canaccord Genuity reiterated its "Buy" rating for GRAIL (Nasdaq: GRAL) on Tuesday, January 13, 2026, setting an...

Via MarketMinute

Adaptive Biotechnologies Surges as Preliminary 2025 Results Signal a Turning Point in MRD Commercialization

January 13, 2026

Shares of Adaptive Biotechnologies (NASDAQ: ADPT) soared on Tuesday, January 13, 2026, after the life sciences company announced preliminary fourth-quarter and full-year 2025 financial results that...

Via MarketMinute

From Silicon to Syringes: Nvidia’s AI Dominance Solidified Through Landmark Eli Lilly Alliance

January 12, 2026

In a move that signals the definitive convergence of high-performance computing and biotechnology, NVIDIA Corporation (NASDAQ: NVDA) and Eli Lilly and Company (NYSE: LLY) announced a massive $1 billion...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

How Is The Market Feeling About Illumina Inc? ↗

January 12, 2026

Via Benzinga

AMD Ignites the ‘Yotta-Scale’ Era: Unveiling the Instinct MI400 and Helios AI Infrastructure at CES 2026

January 08, 2026

LAS VEGAS — In a landmark keynote that has redefined the trajectory of high-performance computing, Advanced Micro Devices, Inc. (NASDAQ:AMD) Chair and CEO Dr. Lisa Su took the stage at CES 2026 to...

Via TokenRing AI

Topics Artificial Intelligence Economy

Harvard’s CHIEF AI: The ‘Swiss Army Knife’ of Pathology Achieving 98% Accuracy in Cancer Diagnosis

January 06, 2026

In a landmark achievement for computational medicine, researchers at Harvard Medical School have developed a "generalist" artificial intelligence model that is fundamentally reshaping the landscape of...

Via TokenRing AI

Topics Artificial Intelligence

The Caracas Coup: Markets Surge as 'Weekend Capture' Reshapes Global Energy and Geopolitics

January 06, 2026

The first full trading week of 2026 has opened with a seismic shift in both the geopolitical landscape and the financial markets. Following the dramatic "weekend capture" of Venezuelan President...

Via MarketMinute

Topics Artificial Intelligence Economy Government

1 Profitable Stock to Own for Decades and 2 Facing Challenges

January 04, 2026

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

ILLUMINA INC (NASDAQ:ILMN) Shows Bull Flag Setup Ahead of Potential Breakout ↗

December 30, 2025

ILLUMINA INC (ILMN) shows a strong technical breakout setup with a high trend rating and a defined bull flag pattern, suggesting a potential entry point for momentum traders.

Via Chartmill

Is Illumina Inc Gaining or Losing Market Support? ↗

December 22, 2025

Via Benzinga

What If the Future Looked Back at Us? A New Sci-Fi Project Explores Gender, Power, and Perspective

December 19, 2025

NEW YORK, N.Y., Dec. 19, 2025 (SEND2PRESS NEWSWIRE) -- What if men had to prove they were marriage material? What if men were judged by their biceps and facial symmetry? What if men needed to smile...

Via Send2Press

Wix Stock Tumbles 50% in One Year — But Is Vibe-Coding AI Platform Base44 the Reason This Fund Is Doubling Down? ↗

December 09, 2025

A major hedge fund just made a beaten-down tech name its largest bet.

Via The Motley Fool

Topics Artificial Intelligence Regulatory Compliance

Why One Fund Dumped $74 Million of Bank OZK Stock Despite a Record $180.5 Million Earnings ↗

December 09, 2025

Why would a fund walk away from a bank that just posted record earnings?

Via The Motley Fool

This Fintech Stock Is Down 70% — But a Hedge Fund Just Boosted Its $66 Million Stake ↗

December 09, 2025

A major hedge fund just made a bold bet on a fintech name that’s quietly turning its fundamentals around — here’s what they’re likely seeing.

Via The Motley Fool

EPAM Stock Is Down 15% This Past Year — But This Fund Is Betting $146 Million on a Turnaround ↗

December 09, 2025

EPAM’s latest results suggest its long slump may be out of sync with its fundamentals — here’s why a major hedge fund just doubled down.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

39 40 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.